Sight Sciences Statistics
Total Valuation
Sight Sciences has a market cap or net worth of $165.96 million. The enterprise value is $97.66 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Sight Sciences has 51.70 million shares outstanding. The number of shares has increased by 3.45% in one year.
| Current Share Class | 51.70M |
| Shares Outstanding | 51.70M |
| Shares Change (YoY) | +3.45% |
| Shares Change (QoQ) | +0.97% |
| Owned by Insiders (%) | 27.46% |
| Owned by Institutions (%) | 35.88% |
| Float | 28.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.08 |
| Forward PS | 2.01 |
| PB Ratio | 2.12 |
| P/TBV Ratio | 2.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.47, with a Debt / Equity ratio of 0.52.
| Current Ratio | 10.47 |
| Quick Ratio | 9.75 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.52 |
Financial Efficiency
Return on equity (ROE) is -52.87% and return on invested capital (ROIC) is -23.67%.
| Return on Equity (ROE) | -52.87% |
| Return on Assets (ROA) | -21.77% |
| Return on Invested Capital (ROIC) | -23.67% |
| Return on Capital Employed (ROCE) | -42.25% |
| Revenue Per Employee | $361,616 |
| Profits Per Employee | -$228,681 |
| Employee Count | 216 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.77 |
Taxes
In the past 12 months, Sight Sciences has paid $260,000 in taxes.
| Income Tax | 260,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.22% in the last 52 weeks. The beta is 2.40, so Sight Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.40 |
| 52-Week Price Change | -40.22% |
| 50-Day Moving Average | 2.71 |
| 200-Day Moving Average | 4.24 |
| Relative Strength Index (RSI) | 62.21 |
| Average Volume (20 Days) | 178,830 |
Short Selling Information
The latest short interest is 1.33 million, so 2.57% of the outstanding shares have been sold short.
| Short Interest | 1.33M |
| Short Previous Month | 1.48M |
| Short % of Shares Out | 2.57% |
| Short % of Float | 4.73% |
| Short Ratio (days to cover) | 6.84 |
Income Statement
In the last 12 months, Sight Sciences had revenue of $78.11 million and -$49.40 million in losses. Loss per share was -$0.98.
| Revenue | 78.11M |
| Gross Profit | 66.91M |
| Operating Income | -49.67M |
| Pretax Income | -52.20M |
| Net Income | -49.40M |
| EBITDA | -49.00M |
| EBIT | -49.67M |
| Loss Per Share | -$0.98 |
Full Income StatementBalance Sheet
The company has $108.77 million in cash and $40.46 million in debt, giving a net cash position of $68.31 million or $1.32 per share.
| Cash & Cash Equivalents | 108.77M |
| Total Debt | 40.46M |
| Net Cash | 68.31M |
| Net Cash Per Share | $1.32 |
| Equity (Book Value) | 77.63M |
| Book Value Per Share | 1.51 |
| Working Capital | 114.78M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$24.17 million and capital expenditures -$268,000, giving a free cash flow of -$24.44 million.
| Operating Cash Flow | -24.17M |
| Capital Expenditures | -268,000 |
| Free Cash Flow | -24.44M |
| FCF Per Share | -$0.47 |
Full Cash Flow StatementMargins
Gross margin is 85.66%, with operating and profit margins of -63.59% and -63.24%.
| Gross Margin | 85.66% |
| Operating Margin | -63.59% |
| Pretax Margin | -62.91% |
| Profit Margin | -63.24% |
| EBITDA Margin | -62.73% |
| EBIT Margin | -63.59% |
| FCF Margin | n/a |
Dividends & Yields
Sight Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.45% |
| Shareholder Yield | -3.45% |
| Earnings Yield | -29.76% |
| FCF Yield | -14.72% |
Analyst Forecast
The average price target for Sight Sciences is $3.92, which is 22.12% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.92 |
| Price Target Difference | 22.12% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sight Sciences has an Altman Z-Score of -0.58 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.58 |
| Piotroski F-Score | 2 |